In gastric cancer, elevated CD3+/CD8+ TIL levels have been linked to superior disease-free and overall survival, as demonstrated by Pereira et al. and Thompson et al., while recent meta-analyses confirmed their independent prognostic impact [37,42,43]. This evidence concerns the gene CD8A and gastric cancer.